Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Operating Activities
Net Income	$ 904	$ 922
Net Income	902	929
Adjustments to reconcile Net Income to Net cash from operating activities:
Depreciation and amortization	923	826
Nuclear fuel amortization	45	39
Allowance for equity funds used during construction	(18)	(20)
Deferred income taxes	285	118
Equity earnings of equity method investees	(77)	(99)
Dividends from equity method investees	129	48
Asset (gains) losses and impairments, net	14	11
Changes in assets and liabilities:
Accounts receivable, net	188	85
Inventories	5	11
Prepaid postretirement benefit costs	(29)	(45)
Accounts payable	(291)	9
Accrued pension liability	(179)	(205)
Accrued postretirement liability	0	(61)
Derivative assets and liabilities	8	24
Regulatory assets and liabilities	203	283
Other current and noncurrent assets and liabilities	(209)	101
Net cash from operating activities	1,901	2,047
Investing Activities
Plant and equipment expenditures — utility	(1,982)	(1,562)
Plant and equipment expenditures — non-utility	(177)	(217)
Acquisition, net of cash acquired	(174)	0
Notes receivable	(81)	0
Proceeds from sale of nuclear decommissioning trust fund assets	594	810
Investment in nuclear decommissioning trust funds	(599)	(810)
Distributions from equity method investees	9	8
Contributions to equity method investees	(128)	(545)
Other	(20)	(20)
Net cash used for investing activities	(2,558)	(2,336)
Financing Activities
Issuance of long-term debt, net of issuance costs	1,433	1,433
Redemption of long-term debt	0	(105)
Short-term borrowings, net	115
Short-term borrowings, net		(544)
Issuance of common stock	0	7
Dividends paid on common stock	(518)	(459)
Contributions from noncontrolling interests, principally REF entities	23	43
Distributions to noncontrolling interests	(44)	(31)
Purchases of noncontrolling interest, principally SGG	(300)	0
Other	(52)	(40)
Net cash from financing activities	657	304
Net Increase (Decrease) in Cash and Cash Equivalents	0	15
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period	76	89
Cash, Cash Equivalents, and Restricted Cash at End of Period	76	104
Supplemental disclosure of non-cash investing and financing activities
Plant and equipment expenditures in accounts payable	292	275
DTE Electric
Operating Activities
Net Income	587	608
Adjustments to reconcile Net Income to Net cash from operating activities:
Depreciation and amortization	694	616
Nuclear fuel amortization	45	39
Allowance for equity funds used during construction	(17)	(14)
Deferred income taxes	66	156
Asset (gains) losses and impairments, net	13	0
Changes in assets and liabilities:
Accounts receivable, net	(20)	(89)
Inventories	(14)	43
Accounts payable	(15)	18
Accrued pension liability — affiliates	(107)	(185)
Accrued postretirement liability — affiliates	(16)	(71)
Regulatory assets and liabilities	178	195
Other current and noncurrent assets and liabilities	(237)	(71)
Net cash from operating activities	1,157	1,245
Investing Activities
Plant and equipment expenditures	(1,611)	(1,248)
Proceeds from sale of nuclear decommissioning trust fund assets	594	810
Investment in nuclear decommissioning trust funds	(599)	(810)
Other	(19)	(7)
Net cash used for investing activities	(1,635)	(1,255)
Financing Activities
Issuance of long-term debt, net of issuance costs	643	520
Short-term borrowings, net — affiliate	(4)	27
Short-term borrowings, net — other	233	(187)
Dividends paid on common stock	(370)	(346)
Other	(16)	(7)
Net cash from financing activities	486	7
Net Increase (Decrease) in Cash and Cash Equivalents	8	(3)
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period	18	15
Cash, Cash Equivalents, and Restricted Cash at End of Period	26	12
Supplemental disclosure of non-cash investing and financing activities
Plant and equipment expenditures in accounts payable	$ 168	$ 152